TY - JOUR
T1 - Endoscopic Ultrasound-Guided Angiotherapy for Gastric Varices
T2 - A Single Center Experience
AU - Khoury, Tawfik
AU - Massarwa, Muhammad
AU - Daher, Saleh
AU - Benson, Ariel A.
AU - Hazou, Wadi
AU - Israeli, Eran
AU - Jacob, Harold
AU - Epstein, Julia
AU - Safadi, Rifaat
N1 - Publisher Copyright:
© 2018 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.
PY - 2019/2
Y1 - 2019/2
N2 - There are limited efficacious therapeutic options for management of gastric variceal bleeding. Treatment modalities include transjugular intrahepatic portosystemic shunt, surgical shunts, and endoscopic interventions, including the recent advancement of endoscopic ultrasound (EUS)-guided coiling. We present a case series of 10 patients with portal hypertension (7 with liver cirrhosis and 3 without cirrhosis), complicated by gastric varices (GV) with bleeding. All cases were treated successfully with EUS-guided coiling leading to variceal eradication. There were 10 occurrences of minimal self-limited bleeding at the puncture site during the procedure, and only one occurrence of major bleeding that necessitated cyanoacrylate glue injection for homeostasis. There were no other adverse events within a mean follow-up time of 9.7 months (range, 1-28 months). Conclusion: In our series, EUS-guided angiotherapy was effective for GV eradication with a high safety profile.
AB - There are limited efficacious therapeutic options for management of gastric variceal bleeding. Treatment modalities include transjugular intrahepatic portosystemic shunt, surgical shunts, and endoscopic interventions, including the recent advancement of endoscopic ultrasound (EUS)-guided coiling. We present a case series of 10 patients with portal hypertension (7 with liver cirrhosis and 3 without cirrhosis), complicated by gastric varices (GV) with bleeding. All cases were treated successfully with EUS-guided coiling leading to variceal eradication. There were 10 occurrences of minimal self-limited bleeding at the puncture site during the procedure, and only one occurrence of major bleeding that necessitated cyanoacrylate glue injection for homeostasis. There were no other adverse events within a mean follow-up time of 9.7 months (range, 1-28 months). Conclusion: In our series, EUS-guided angiotherapy was effective for GV eradication with a high safety profile.
UR - http://www.scopus.com/inward/record.url?scp=85107711356&partnerID=8YFLogxK
U2 - 10.1002/hep4.1289
DO - 10.1002/hep4.1289
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 30766958
AN - SCOPUS:85107711356
SN - 2471-254X
VL - 3
SP - 207
EP - 212
JO - Hepatology Communications
JF - Hepatology Communications
IS - 2
ER -